Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.
2.

Severe acute respiratory syndrome coronavirus entry as a target of antiviral therapies.

Kuhn JH, Li W, Radoshitzky SR, Choe H, Farzan M.

Antivir Ther. 2007;12(4 Pt B):639-50. Review.

PMID:
17944271
3.

Insights from the association of SARS-CoV S-protein with its receptor, ACE2.

Li W, Choe H, Farzan M.

Adv Exp Med Biol. 2006;581:209-18. Review. No abstract available.

PMID:
17037532
4.

The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S.

Nat Rev Microbiol. 2009 Mar;7(3):226-36. doi: 10.1038/nrmicro2090. Review.

5.

Severe acute respiratory syndrome coronavirus entry into host cells: Opportunities for therapeutic intervention.

Yeung KS, Yamanaka GA, Meanwell NA.

Med Res Rev. 2006 Jul;26(4):414-33. Review.

PMID:
16521129
6.

Receptor recognition and cross-species infections of SARS coronavirus.

Li F.

Antiviral Res. 2013 Oct;100(1):246-54. doi: 10.1016/j.antiviral.2013.08.014. Review.

7.

Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus.

Kuhn JH, Li W, Choe H, Farzan M.

Cell Mol Life Sci. 2004 Nov;61(21):2738-43. Review.

PMID:
15549175
8.

Infection of human airway epithelia by SARS coronavirus is associated with ACE2 expression and localization.

Jia HP, Look DC, Hickey M, Shi L, Pewe L, Netland J, Farzan M, Wohlford-Lenane C, Perlman S, McCray PB Jr.

Adv Exp Med Biol. 2006;581:479-84. Review. No abstract available.

PMID:
17037581
9.

Attachment factor and receptor engagement of SARS coronavirus and human coronavirus NL63.

Hofmann H, Marzi A, Gramberg T, Geier M, Pyrc K, van der Hoek L, Berkhout B, Pöhlmann S.

Adv Exp Med Biol. 2006;581:219-27. Review. No abstract available.

PMID:
17037533

Supplemental Content

Support Center